Tablet & Teva Block Sun As Generic Competition For Wyeth’s Effexor XR

Wyeth is anticipating it will be able to block entry of Sun Pharmaceuticals' generic version of Effexor XR because of the brand firm's existing deal with first-to-file Teva and the alternate venlafaxine dosage form that Sun is using in its ANDA

More from Archive

More from Pink Sheet